MannKind | MNKD - Ordinary Share Capital


MannKind reported $309.91M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Adma Biologics USD 232.29M 5.59M Mar/2026
BioCryst Pharmaceuticals USD 255.26M 42.2M Jun/2026
Eli Lilly USD 943.5M 3.33M Mar/2026
Halozyme Therapeutics USD 114.04M 4.48M Jun/2026
Insmed USD 218.28M 1.76M Jun/2026
Karyopharm Therapeutics USD 22.54M 4.23M Mar/2026
MacroGenics USD 63.56M 241K Mar/2026
MannKind USD 309.91M 1M Jun/2026
Merck USD 2.47B 4.93M Mar/2026
Minerva Neurosciences USD 1000 0 Sep/2024
Novavax USD 162.58M 106K Dec/2025
Novo Nordisk DKK 4.43B 13.25M Jun/2026
Pfizer USD 5.7B 0 Jun/2026
Sanofi EUR 1.21B 8.25M Mar/2026
Xencor USD 74.33M 265K Jun/2026